SCN9A anticorps (C-Term)
-
- Antigène Voir toutes SCN9A Anticorps
- SCN9A (Sodium Channel, Voltage-Gated, Type IX, alpha Subunit (SCN9A))
-
Épitope
- C-Term
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp SCN9A est non-conjugé
-
Application
- Immunohistochemistry (IHC), Western Blotting (WB), Immunoprecipitation (IP), Fluorescence Microscopy (FM)
- Réactivité croisée
- Humain, Souris, Rat (Rattus)
- Purification
- Anti-NAV1.7 Antibody was purified by Protein G chromatography. A BLAST analysis was used to suggest cross-reactivity with NAV1.7 from Human, Rat, and Mouse based on 100% homology with the immunizing sequence. No cross-reactivity against other Nav channels. Cross-reactivity with NAV1.7 from other sources has not been determined. Channels and Transporters research.
- Immunogène
-
Immunogen: Nav1.7 Antibody was produced in mice by repeated immunizations raised against a fusion protein corresponding to the cytoplasmic C-terminus region of human Nav1.7.
Immunogen Type: Recombinant Protein
- Clone
- S68-6
- Isotype
- IgG1
- Top Product
- Discover our top product SCN9A Anticorps primaire
-
-
- Indications d'application
-
Immunohistochemistry Dilution: 0.1-1.0 μg/mL
Application Note: Anti-NAV1.7 Antibody is suitable for use in WB, IP, and IF microscopy. Expect a band approximately ~230 kDa on specific lysates. Specific conditions for reactivity should be optimized by the end user.
Immunoprecipitation Dilution: User Optimized
Western Blot Dilution: 1-10 μg/mL
IF Microscopy Dilution: 1.0-10 μg/mL
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Stabilizer: 50 % (v/v) Glycerol
0.09 % (w/v) Sodium Azide - Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- RT,4 °C,-20 °C
- Stockage commentaire
- Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
-
- Antigène
- SCN9A (Sodium Channel, Voltage-Gated, Type IX, alpha Subunit (SCN9A))
- Autre désignation
- NAV1.7 (SCN9A Produits)
- Synonymes
- anticorps SCN9A, anticorps DKFZp459G084, anticorps Nav1.7, anticorps PN1, anticorps mKIAA4197, anticorps Scn2a, anticorps ETHA, anticorps FEB3B, anticorps GEFSP7, anticorps NE-NA, anticorps NENA, anticorps SFNP, anticorps sodium channel, voltage-gated, type IX, alpha subunit, anticorps sodium voltage-gated channel alpha subunit 9, anticorps sodium channel protein type 9 subunit alpha, anticorps sodium channel, voltage-gated, type IX, alpha, anticorps SCN9A, anticorps LOC100016648, anticorps Scn9a
- Sujet
-
Synonyms: ETHA, hNE Na, NENA, PN1, SCN9A, voltage gated sodium channel subunit alpha Nav1.7, peripheral sodium channel 1, neuroendocrine sodium channel, Sodium channel protein type 9 subunit alpha
Background: Nav1.7 is a voltage-gated sodium channel and plays a critical role in the generation and conduction of action potentials and is thus important for electrical signaling by most excitable cells. Therapeutically, the association of pain insensitivity with the loss of function of a certain sodium channel may have implications. Since Nav1.7 is not present in cardiac muscle or neurons in the central nervous system, blockers of Nav1.7 will not have direct action on these cells and thus can have less side effects than current pain medications. By performing more studies, there is a possibility to develop a new generation of drugs that can reduce the pain intensity in animals.
Gene Name: Scn9a
- ID gène
- 6335
- NCBI Accession
- NP_002968
- UniProt
- Q15858
-